FdaApplication

ANDA 203333

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL MOLECULAR HOLDINGS LLC
application_typeANDA
approval_date2016-03-15

Products (6)

ProductActive ingredientStrengthDosage form
OLANZAPINEOLANZAPINE5MGTABLET;ORAL
OLANZAPINEOLANZAPINE7.5MGTABLET;ORAL
OLANZAPINEOLANZAPINE10MGTABLET;ORAL
OLANZAPINEOLANZAPINE15MGTABLET;ORAL
OLANZAPINEOLANZAPINE2.5MGTABLET;ORAL
OLANZAPINEOLANZAPINE20MGTABLET;ORAL

6 products